Holen Sie sich die Stockscreener-App
1.84
0.54%
-0.01
Handel nachbörslich:
1.78
-0.06
-3.26%
Schlusskurs vom Vortag:
$1.85
Offen:
$1.88
24-Stunden-Volumen:
1.09M
Relative Volume:
0.86
Marktkapitalisierung:
$135.96M
Einnahmen:
$302.48M
Nettoeinkommen (Verlust:
$-265.26M
KGV:
-0.4952
EPS:
-3.716
Netto-Cashflow:
$-2.76M
1W Leistung:
+5.44%
1M Leistung:
+54.62%
6M Leistung:
-21.70%
1J Leistung:
-51.52%
1-Tages-Spanne:
$1.75
$1.92
1-Wochen-Bereich:
$1.53
$1.92
52-Wochen-Spanne:
$0.9551
$4.125
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.84 | 136.70M | 302.48M | -265.26M | -2.76M | -3.716 |
VEEV
Veeva Systems Inc
|
162.17 | 25.92B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.08 | 12.41B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.32 | 8.59B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
86.97 | 7.39B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
68.35 | 5.06B | 646.34M | -512.40M | 202.76M | -6.6871 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Health Catalyst (HCAT) CEO uses 34,485 shares to cover RSU tax bill - Stock Titan
Health Catalyst jumps on announcement to sell Vitalware to Med‑Metrix for $147M - MSN
HCAT News | HEALTH CATALYST INC (NASDAQ:HCAT) - ChartMill
Health Catalyst (HCAT) Form 144: 34,485 restricted shares planned sale 06/10/2026 - Stock Titan
Health Catalyst, Tenable, and Pegasystems Stocks Trade Down, What You Need To Know - Yahoo Finance
Health Catalyst to Cut 9% of Workforce - Moomoo
Whetstone updates Health Catalyst (HCAT) ownership to 4.5% stake - Stock Titan
Health Catalyst, Inc. - MLQ.ai
HCAT's Vitalware sale brings relief, and a reckoning - Axios
Health Catalyst Inc (HCAT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Health Catalyst Company Profile & Introduction - Moomoo
Veru And 2 Other Intriguing Penny Stocks To Watch - simplywall.st
Med-Metrix to acquire Vitalware to strengthen net revenue yield - ROI-NJ
3 Russell 2000 Stocks That Fall Short - The Globe and Mail
Health Catalyst to Divest Vitalware Unit for $147M to Med-Metrix - HIT Consultant
Latham & Watkins Advises Health Catalyst on Divestiture of Vitalware - Latham & Watkins LLP
Health Catalyst to Sell Vitalware for $147 Million; Shares Rise Pre-Bell - Moomoo
Health Catalyst to sell Vitalware unit for $147 million cash By Investing.com - Investing.com Nigeria
Med-Metrix, LLC entered into a definitive agreement to acquire Vitalware, LLC from Health Catalyst, Inc.. - marketscreener.com
Health Catalyst (HCAT) Divests Vitalware for $147 Million - GuruFocus
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Didn't see the 300%—it's pretty obvious when you keep losing money 🥲 - Moomoo
Med-Metrix to acquire Vitalware from Health Catalyst By Investing.com - Investing.com Australia
Med-Metrix to acquire Vitalware from Health Catalyst - Investing.com UK
Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield - PR Newswire
HCAT Stock Jumps As Strategic Reset Follows Earnings Beat - StocksToTrade
Health Catalyst to sell Vitalware unit for $147 million cash - Investing.com
Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation - The Manila Times
Health Catalyst to Sell Vitalware Business to Med-Metrix for $147 Million, Repay Term Loan - TradingView
Health Catalyst Announces Divestiture of Vitalware to Med-Metrix for $147 Million - Quiver Quantitative
Health Catalyst (NASDAQ: HCAT) divests Vitalware to repay term loan debt - Stock Titan
Selling a side business, Health Catalyst plans to pay off $160M loan - Stock Titan
Small tax-withholding sale by Health Catalyst (HCAT) CEO disclosed - Stock Titan
Health Catalyst (HCAT) CPO uses 8,519 shares in mandated tax sell-to-cover - Stock Titan
Health Catalyst (HCAT) CFO mandated share sale to cover RSU taxes - Stock Titan
Health Catalyst (HCAT) General Counsel sells shares to cover RSU tax withholding - Stock Titan
Health Catalyst (HCAT) director awarded 12,710 RSUs, now holds 94,644 shares - Stock Titan
Health Catalyst (HCAT) investors to vote on declassifying board and pay - Stock Titan
Health Catalyst Inc stock (US42226A1079): Insider share sale surfaces as earnings backdrop stays in - AD HOC NEWS
Benjamin Albert files to sell 336 HCAT shares (HCAT) - Stock Titan
Health Catalyst (HCAT) affiliate files to sell 18,804 restricted shares on 06/01/2026 - Stock Titan
Linda Llewelyn files to sell 8,519 restricted shares (HCAT) - Stock Titan
Health Catalyst (HCAT) Rule 144: insider sale of 13,779 restricted shares - Stock Titan
What's Driving the Recent Buzz Around Health Catalyst (HCAT) and ZoomInfo (ZI) Stocks - Kavout
Health Catalyst Inc stock (US42226A1079): shares edge higher as Nasdaq health-data name digests late - AD HOC NEWS
Health Catalyst | 4: Statement of changes in beneficial ownership of securities-Director Nelson Steven H - Moomoo
Health Catalyst Inc (HCAT) Share Price Today | Health Catalyst (HCAT) Live NSE/BSE - Value Research
Health Catalyst Q1 2026 Results: Revenue Decline, Client Migration Issues, and Strategic ShiftsNews and Statistics - IndexBox
EDGAR Filing Documents for 0001636422-25-000010 - SEC.gov
MongoDB, Health Catalyst, and Qualys Shares Are Soaring, What You Need To Know - Yahoo Finance
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
3.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):